Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Haruhiro Saito

Real-World Effectiveness and Safety of Nivolumab in Patients With Non-Small Cell Lung Cancer: A Multicenter Retrospective Observational Study in Japan

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Phase II Study of Bevacizumab, Cisplatin, and Docetaxel Plus Maintenance Bevacizumab as First-Line Treatment for Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer Combined With Exploratory Analysis of Circulating Endothelial Cells: Thoracic Oncology Research Group (TORG)1016

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Related publications

Real-World Data on Nivolumab Treatment of Non-Small Cell Lung Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2016English

Observational Study on the Efficacy and Safety of Erlotinib in Patients With Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2012English

Re-Biopsy Status Among Non-Small Cell Lung Cancer Patients in Japan: A Retrospective Study

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2016English

Effectiveness and Safety of Nivolumab in the Treatment of Lung Cancer Patients in France: Preliminary Results From the Real-World EVIDENS Study

OncoImmunology
OncologyAllergyImmunology
2020English

P3.01-103 Efficacy of Crizotinib in Chinese Non-Small Cell Lung Cancer Patients With Brain Metastasis: A Multicenter Retrospective Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Osimertinib, a Third‐generation EGFR Tyrosine Kinase Inhibitor: A Retrospective Multicenter Study of Its Real‐world Efficacy and Safety in Advanced/Recurrent Non‐small Cell Lung Carcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2020English

Association of Genetic and Immuno-Characteristics With Clinical Outcomes in Patients With RET-rearranged Non-Small Cell Lung Cancer: A Retrospective Multicenter Study

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2020English

Ceritinib Plus Nivolumab in Patients With Advanced ALK-rearranged Non-Small-Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy